Emmanuel Ngabirano's Clinical Contribution and Expansion of the Operational Licence

1. fIsButton1fLayoutInCell1
Baylor College of Medicine Children's Foundation-UgandaBlock 5, Mulago Hospital P.O. Box 72052, Clock Tower
Kampala – UGANDATel:+256‐0417‐119100/125E‐mail:admin@baylor‐uganda.org www.bayloraids.org
C/o Baylor College of Medicine USA through International Medical Professional Resistances (IMPR)
Baylor College of Medicine Children's Foundation Uganda (Baylor Uganda) is an indigenous not for-profit child health
and development organization affiliated to the Baylor International Pediatric AIDS Initiative (BIPAI).BIPAI is a global
partnership established in 1996 at Baylor College of Medicine in Houston ,Texas USA working to expand access to
pediatric HIV/AIDS services.
Baylor Uganda was established in 2003 at the Pediatrics Infectious Diseases Clinic in Ward 15 of the National
Referral Hospital Mulago.2006; the organization was fully registered as an NGO and currently operates at the Baylor
College of Medicine Bristol Myers Squibb Children’s Clinical Centre of Excellence (COE).
Emmanuel Ngabirano graduated as an outstanding expert in Treatment and diagnosis of HIV individuals with Baylor
College of Medicine USA testing his modules at the Baylor Uganda Clinic, Emmanuel’s Clinical Trails research
focused on Pharmacokinetics of Antiretroviral Drugs and initiated the first second line treatment of HAART-Highly
Active Antiretroviral Therapy in patients during their early initiation of ART.
Emmanuel’s contribution is supporting and conducting different Clinical trials at the Infectious Diseases Institute an
Adult clinic for complicated cases of HIV and other infectious Diseases in urban Kampala, Trials and successful
papers written include;
“A prospective study of HIV-infected adolescents: monitoring growth, development and recovery while on antiretroviral
therapy”
“The Dual Importance of Immunologic and Virologic Monitoring of Antiretroviral Therapy in Resource-limited Settings”
“Comparison of two manual bead-based assays (Dyanbeads and Cytospheres) to FACScount at a public, urban clinic
in Kampala, Uganda”
“Cryptoccocal Meningitis a common cause of mortality among AIDS patients initiated on HAART” to mention but a
few
We therefore acknowledge your contribution and seek for your further continuous support to Baylor Uganda Training
and Research Department for the next 3 years
Yours truly,
Cc, Dr.Emmanuel Ngabirano
Infectious Diseases Institute-Makerere University